[Therapeutic strategy by manipulating some protease activities for Alzheimer's disease].
Iwata
Nobuhisa
N
iwatan@brain.riken.jp
Higuchi
Makoto
M
Saido
Takaomi C
TC
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000209:etiology*; D053829:Amyloid Precursor Protein Secretases / Q000037:antagonists & inhibitors* / Q000502:physiology; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D016564:Amyloid beta-Protein Precursor / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000378:metabolism*; D002118:Calcium / Q000502:physiology; D002154:Calpain / Q000037:antagonists & inhibitors* / Q000502:physiology; D015195:Drug Design; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D015260:Neprilysin / Q000378:metabolism / Q000502:physiology*; D010766:Phosphorylation; D013004:Somatostatin / Q000494:pharmacology / Q000627:therapeutic use*; D016875:tau Proteins / Q000378:metabolism
D016229:Amyloid beta-Peptides; D016564:Amyloid beta-Protein Precursor; D004791:Enzyme Inhibitors; D016875:tau Proteins; D013004:Somatostatin; D053829:Amyloid Precursor Protein Secretases; D002154:Calpain; D015260:Neprilysin; D002118:Calcium